| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |